^

Health

Specific immunity: development and establishment

, medical expert
Last reviewed: 04.07.2025
Fact-checked
х

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

Specific immunological reactions are performed by the body's immune system, which consists of central and peripheral organs of immunogenesis. Specific immunity when exposed to a certain antigen is carried out by T- and B-lymphocytes. The intrauterine period demonstrates intensive dynamics of maturation of the lymphoid system.

The sequential change of various stages of maturation of cells of the B- and T-systems can be controlled by immunological markers of the corresponding stages of maturation or differentiation.

Differentiation markers of cells involved in the immune response

CD marker

Type of cell carrying the marker

Function

CD1

T-lymphocyte

Participation in antigen presentation

CD2

T-lymphocyte

Adhesion of cytotoxic T-lymphocytes to the endothelium, to the epithelial cells of the thymus gland

SDZ

T-lymphocyte

Conduction of the T-cell activation signal, a marker of most mature T-lymphocytes

CD4

T-lymphocyte

Co-receptor for TCR, marker of T-helper cells

CD8

T-lymphocyte

Maturation and selection of GCS-restricted lymphocytes in the thymus gland, a marker of cytotoxic T-lymphocytes

CD25

T-, B-, NK-cells, thymocytes, macrophages

Induction of activity and proliferation of T and B lymphocytes, natural killers, thymocytes and macrophages, α-subunit of the receptor for IL-2

CD28

T-lymphocyte

TCR-independent costimulatory signaling molecule

СDЗ0

T-lymphocyte

Conducting a signal to trigger T-lymphocyte apoptosis

CD5

T and B lymphocyte

Specific for autoimmune diseases

CD9

B-lymphocyte

Present on pre-B cells, responsible for platelet aggregation and activation

CD19, 20, 21

B-lymphocyte

Regulation of B-lymphocyte activation and proliferation

CD22

B-lymphocyte

Responsible for adhesion to erythrocytes, T and B lymphocytes, monocytes and neutrophils

CD40

B-lymphocyte

B-cell activation, proliferation and differentiation

CD16 Natural killer Activation of antigen-dependent complement-mediated cytotoxicity and cytokine production

CD56

Natural killer

Activation of cytotoxicity and cytokine production

CD94

Natural killer

Inhibition/activation of natural killer cell cytotoxicity

CD11α
CD18

Monocyte
Granulocyte

Adhesion of leukocytes to endothelium and leukocyte to leukocyte

CD11β
CD18

Monocyte
Granulocyte

Adhesion of monocytes and neutrophils to the endothelium, opsonization of complement-bound particles

C11c CD18tov

Monocyte
Granulocyte

Adhesion of monocytes and granulocytes to the endothelium, phagocytic receptor in inflammation

CD45

Granulocyte

Receptor for tyrosine phosphatase

CD64

Macrophages

Activation of macrophages

CD34

Stem cell or
committed
colony-forming
progenitor

Attachment of lymphocyte L-selectin to endothelium, attachment of stem cells to bone marrow stroma

B-lymphocyte differentiation markers

Pro/pre-B-1 cell

Large pre-B-97-N cell

Small pre-B-97-II cell

Immature B cell

Mature B cell

CD34

CD40

CD40

CD21

CD40

CD40

CD43

CD22

CD19

CD43

CD19

CD80

CD20

B220

CD86

CD25

CD54

CD79

T-lymphocyte differentiation markers

Pro-T cells TH

Pre-T cells

Immature TN T cells

DP cells

Mature

CD25

CD25

CDZeu

SDZ

CD4

CD44

CDZeu

CD4

CD4+, 8+

CD8

CD117

CD4-

CD8

CD4

SDZ

C3-

CD8-

CD117

CD8

CD4

C4-

CD117

CD8

CD8"

TKP-β

Rearrangement

The development of all systems of both non-specific and specific immunity, primarily cellular, begins at about 2-3 weeks, when multipotent stem cells are formed. The common stem cell-predecessor of all subpopulations of lymphocytes, neutrophilic leukocytes and monocytes can be identified as a CD34+ T-cell.

T-precursors undergo a maturation cycle in the thymus gland and undergo negative and positive selection processes there, the result of which is the elimination of more than 90% of lymphoid cells that are potentially dangerous to the body in terms of the risk of developing autoimmune reactions. The cells remaining after selection migrate and populate the lymph nodes, spleen and group lymphatic follicles.

In the 3rd month, a positive blast transformation reaction to phytohemagglutinin is already noted, which coincides with the division of the thymus gland into the cortex and the medullary part. By the 9th-15th week of life, signs of functioning of cellular immunity appear. The delayed-type hypersensitivity reaction is formed at later stages of intrauterine development and reaches its greatest functioning after birth - by the end of the first year of life.

The primary lymphoid organ, the thymus gland, is laid down at about 6 weeks and finally matures histomorphologically by the gestational age of about 3 months. From 6 weeks, HLA antigens begin to be typed in the fetus. This means that already from this period the fetus becomes an "immunological personality" with its individual antigen constitutional "portrait" and many constitutional features in all reactions of the immune system. From the 8th-9th week, small lymphocytes appear in the thymus gland. They are recognized as descendants of lymphoid cells that migrated first from the yolk sac, and later from the liver or bone marrow. Then there is an intensive increase in the number of lymphocytes in the peripheral blood of the fetus - from 1000 in 1 mm3 at the 12th week to 10,000 in 1 mm3 by the 20th-25th week.

Under the influence of humoral stimulators and partially the local microenvironment, T-lymphocytes can assume the functions of cytotoxic cells, helpers, suppressors, and memory cells. By the time of birth, the absolute number of T-lymphocytes in a child is higher than in an adult, and functionally this system is quite capable, although many characteristics of the T-lymphocyte function are at a lower level than in older children and adults. They have a weakened ability to produce interleukins 4 and 5, interferon-γ, and the CD40β antigen, which is necessary for organizing the interaction of the T- and B-systems in the immune response, is weakly expressed.

The characteristics of the features of the immune response are largely determined by the ability of the cells involved to produce humoral communication substances and regulate cytokines or interleukins. Several dozen such information and regulatory molecules have already been identified and quantitatively studied in scientific research. In clinical immunology, the greatest importance is given to identifying 10-15 biologically active substances of this group.

Early morphological and functional maturation of the thymus gland coincides with the advanced development of the T-cell system. Reactions of transplant rejection have been described, starting from 12 weeks of gestation. By the time of birth, the lymphoid tissue of the thymus gland already has significant dimensions.

The first peripheral lymphatic glands are formed starting from the 3rd month of gestation, but their "population" with lymphoid elements occurs during the following (4th) month. Lymph nodes and formations of the gastrointestinal tract are formed only after the 21st week of gestation.

Differentiation of B cells also begins in the liver or bone marrow, and there is a close connection of this differentiation with the Bruton tyrosine kinase gene. In the absence of this gene, differentiation is impossible and the child will suffer from agammaglobulinemia. During the differentiation of B lymphocytes, deletional recombination with immunoglobulin genes occurs. This allows B cells to present the structure of immunoglobulin M on their surface and, as a result, migrate and repopulate in the spleen and lymph nodes. During a long period of intrauterine development, the dominant B cells in the liver and peripheral blood remain pre-B lymphocytes, which contain heavy M globulin chains in their cytoplasm, but do not carry surface receptors for immunoglobulins. The number of these cells decreases significantly by the time of birth. The transformation of pre-B cells into cells capable of producing immunoglobulins is carried out under the influence of thymus factors. For the final maturation of B cells with the possibility of their transformation into plasma cells, the participation of the immediate microenvironment is necessary, i.e., stromal elements of the lymph nodes, group lymphatic follicles of the intestine, and the spleen.

trusted-source[ 1 ], [ 2 ], [ 3 ], [ 4 ], [ 5 ], [ 6 ], [ 7 ], [ 8 ]

Specific immunity and interleukins

Interleukin

Source of education

Functions

IL-1

Macrophages, dendritic cells, fibroblasts, NK cells, endothelial cells

Acceleration of antigen presentation, stimulates production of IL-2 by Th cells, maturation of B lymphocytes, pro-inflammatory and pyrogenic action

IL-2

Activated T lymphocytes (predominantly Th1)

Growth factor for T and B lymphocytes, activates differentiation of Th and cytotoxic T lymphocytes, stimulates NK cells and Ig synthesis by B lymphocytes

IL-3

T cells and stem cells

Plasma cell growth factor, multicolony stimulating factor

IL-4

Th2 cells, mast cells

Differentiation of Th0 into Th2 cells, B-differentiation, acceleration of IgE synthesis, growth of plasma cells, suppresses the formation of cytotoxic lymphocytes and NK cells, suppresses the formation of interferon-γ

IL-5

Th2 cells

Acceleration of the synthesis of immunoglobulins, especially IgA, acceleration of the production of eosinophils

IL-6

T and B lymphocytes, macrophages, fibroblasts, endothelial cells

Acceleration of immunoglobulin synthesis, stimulates proliferation of B-lymphocytes, hepatocyte growth factor, antiviral protection

IL-7

Stromal cells, fibroblasts, endothelial cells, T lymphocytes, bone marrow cells

Acceleration of pre-T and pre-B cell growth

IL-8

T cells, macrophages, endothelial cells, fibroblasts, hepatocytes

Neutrophil activation, chemoattractant for lymphocytes, neutrophils, macrophages and eosinophils

IL-9

Th2 cells

Synergism with IL-4 in increasing IgE synthesis, plasma cell growth, stimulates proliferation of T-lymphocytes and basophils

IL-10

Th0 and Th2 cells, CD8+, macrophages, dendritic cells

Factor inhibiting the synthesis of proinflammatory cytokines, suppressing the functions of macrophages, accelerating the growth of B-lymphocytes and mast cells

IL-12

Macrophages, neutrophils, B lymphocytes and dendritic cells

Stimulation of natural killers, maturation of lymphocyte cytotoxicity, stimulates growth and differentiation of TM- into Th1 cells, inhibits the synthesis of IgE, a proinflammatory cytokine

IL-13

Th2 cells and mast cells

Acceleration of IgE synthesis, acceleration of B-lymphocyte growth, inhibition of macrophage activation

IL-14

T and B lymphocytes

Reduces Ig production, increases proliferation of B-lymphocytes

IL-15

Monocytes and epithelial cells

Growth factor for T-lymphocytes, activates differentiation of Th- and cytotoxic T-lymphocytes, stimulates NK-cells and Ig synthesis by B-lymphocytes

IL-16 Eosinophils, CD8+, mast cells Activates chemotaxis of Th cells, eosinophils and monocytes

IL-17

Memory T cells and NK cells

Enhances the production of IL-6, IL-8, enhances the expression of ICAM-1, stimulates the activity of fibroblasts

IL-18

Macrophages

Acceleration of interferon-γ synthesis

IL-19

Monocytes

IL-10 homolog

IL-20

Keratinocytes

Participates in skin inflammation in psoriasis

IL-21

T lymphocytes and mast cells

Enhances proliferation of T, B lymphocytes and NK cells

IL-22

T-lymphocytes

IL-10 homolog

IL-23

Activated dendritic cells

Increases the proliferation of CD4+ memory T-lymphocytes and stimulates the production of interferon-γ

IL-24

Activated monocytes, T lymphocytes

IL-10 homolog

IL-25

Bone marrow stromal cells

Increases production of Th2 cytokines

IL-26

Activated monocytes, T lymphocytes, NK cells

IL-10 homolog

Interferon-γ

T cells

Activation of macrophages, inhibition of IgE synthesis, antiviral activity

Tumor necrosis factor

Monocytes, macrophages, T and B lymphocytes, neutrophils, NK cells, endothelial cells

Induces the synthesis of IL-1 and IL-6 by macrophages, the formation of acute phase proteins, stimulates angiogenesis, induces apoptosis, hemorrhagic necrosis of tumors

Chemokines (RANTES, MIP, MCP)

T cells, endothelium

Chemoattractant (chemokine) for monocytes, eosinophils, T-cells

Relatively mature B-lymphocytes are identified by the presence of immunoglobulin antigen receptors on their surface. In the liver, such cells begin to be detected after 8 weeks. At first, these are receptors for immunoglobulins G and M, later - for A. After the 20th week, cells with receptors are already detected in the spleen and peripheral blood.

The ability to produce antibodies by the B-system cells themselves has been confirmed in the fetus starting from the 11th-12th week. The earliest the fetus acquires the ability to form immunoglobulin M (from the 3rd month), somewhat later immunoglobulin B (from the 5th month) and immunoglobulin A (from the 7th month). The timing of immunoglobulin D synthesis in the prenatal period has not been sufficiently studied. The fetus's own production of immunoglobulin E is detected from the 11th week in the lungs and liver, and from the 21st week - in the spleen. Many lymphocytes carrying immunoglobulin E are found in the umbilical cord blood, but the content of immunoglobulin E itself is very low. Up to the 37th week of gestational age, it is no more than 0.5 IU / ml. At the age of 38 weeks, immunoglobulin E is determined in 20% of newborns, and after the 40th week - in 34%.

In general, the synthesis of immunoglobulins during intrauterine development is very limited and is enhanced only by antigen stimulation (for example, by intrauterine infection). The humoral immune response of the fetus and newborn differs significantly from the response of an older child or an adult, both qualitatively and quantitatively.

At the same time, during the period of intrauterine development, some maternal immunoglobulins are transferred transplacentally to the fetus. Among the latter, immunoglobulin B has this ability. The transfer of maternal immunoglobulin M to the fetus is possible only due to increased permeability of the placenta. As a rule, this is observed only in gynecological diseases of the mother, for example, in endometritis. Other classes of maternal immunoglobulins (A, E, D) do not transfer transplacentally.

The presence of selective transport of maternal immunoglobulin B through the placenta can be considered a significant factor in perinatal adaptation. This transition begins after the 12th week of gestation and increases with its duration. It is very important that the child receives from the mother a wide range of specific antibodies, both antibacterial and antiviral, aimed at protecting him from the range of pathogens that his mother encountered and that are important in the local environment. The transition of immunoglobulin B2 through the placenta is especially easy.

It is obvious that the reverse transition of fetal immunoglobulins and even the child's lymphocytes into the mother's blood is possible, although in an insignificant amount, which creates a risk of her immunization to alloantigens of fetal immunoglobulins. It is believed that this mechanism may be important in the formation of the mechanism of suppression of alloantigen synthesis by the fetus. Immunodepression of a woman and mutual immunological tolerance during pregnancy are evolutionarily developed adaptations that allow, despite the antigenic difference between the mother and fetus, to ensure the normal course of pregnancy and the birth of children on time.

After birth, the ratio of T- and B-cells in the blood of newborns fluctuates significantly. The content of T- and B-lymphocytes in the peripheral blood of newborns is higher, and it decreases with age. A more pronounced blast transformation reaction is also noteworthy - both spontaneous and stimulated by phytohemagglutinin. However, in functional terms, lymphocytes are less active, which is explained, on the one hand, by immunodepression by substances transferred from the woman's body during pregnancy, and on the other hand, by the absence of antigenic stimulation of the fetus in utero. Evidence of the latter position is an increase in the content of immunoglobulins A and, to a lesser extent, immunoglobulins M in newborns who have had an intrauterine infection or are suffering from it.

A very complex mechanism of differentiation and "learning" is presented in the selection of clones capable of producing antibodies to factors of the normal habitat, or in the active prolongation of reactions of this kind. We can talk about perinatal aspects of the formation of allergenic tolerance or allergic predisposition (atopic diathesis). The development of tolerance to allergens (atopenes) in the intrauterine period is carried out under the influence of the allergens themselves, easily penetrating the placental barrier, but mainly - through the penetration of allergen-antibody immune complexes. The inability of allergens and immune complexes to cause tolerance often becomes the cause of intrauterine sensitization. In recent decades, there has been a widespread prevalence of food allergies, and the importance of intrauterine sensitization is convincingly confirmed.

During the development of allergic reactivity, the characteristics of the first "contacts" of the immune system with antigens or allergens of the external environment may have a possible and significant impact. It has been revealed that already in the first hours of life, acquaintance with antigens related to the competence of the response chains emanating from cytokines of one of the T-helper subpopulations - Th1 or Th2, may be decisive regarding the subsequent development of atopic diathesis. The dominance of Th2 production at the end of intrauterine life is adaptive in nature and is aimed at protecting the placenta from potential Th toxicity. This dominance may persist for some time after birth. During this period, the phenomenon of an "open window" for external sensitization and the launch of a stereotype for reactions of atopic reactivity is noted. According to preliminary data, protecting a child from contact with atopenes or competitive exposure to antigens including Th helper populations may become an example of “organized early experience” for the immunocompetent system, leading to the most effective prevention of allergic diseases.

There is also sufficient evidence of the importance of specific allergens that affect the newborn in the first hours and days of life. The consequence of such "early experience" or acquaintance with an allergen may be the establishment of clinically significant sensitization with its detection after many years of life. In the complex immunological restructuring of the primary adaptation of the newborn, the role of another participant or mechanism of adaptation is evolutionarily determined - these are the peculiarities of the newborn's nutrition, special functions of maternal colostrum and milk from the very first hours of postnatal life.

You are reporting a typo in the following text:
Simply click the "Send typo report" button to complete the report. You can also include a comment.